Aurora Cannabis Inc. (TSX:ACB)
Canada · Delayed Price · Currency is CAD | Market Cap | 361.28M -13.3% |
| Revenue (ttm) | 314.07M +12.3% |
| Net Income | -120.13M |
| EPS | -2.07 |
| Shares Out | 64.86M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 280,923 |
| Open | 5.52 |
| Previous Close | 5.55 |
| Day's Range | 5.47 - 5.61 |
| 52-Week Range | 3.59 - 9.33 |
| Beta | 1.34 |
| Analysts | Buy |
| Price Target | 5.38 (-3.41%) |
| Earnings Date | Aug 5, 2026 |
About Aurora Cannabis
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient ... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsAnalyst Summary
According to 5 analysts, the average rating for ACB stock is "Buy." The 12-month stock price target is $5.38, which is a decrease of -3.41% from the latest price.
News
Is Aurora Cannabis Stock a Buy as Curaleaf Pushes a Hostile Takeover Bid?
Curaleaf is offering Aurora shareholders $4 per share. Aurora believes Curaleaf's hostile bid undervalues the company.
The Best Way Marijuana Stock Investing Can Work For You
As the cannabis industry continues to grow worldwide, there is a strong focus on the future. Many new changes are occurring throughout the sector—many of these impact businesses, investors, and potent...
Curaleaf says Aurora’s characterization of engagement ‘misleading’
Curaleaf Holdings (CURLF) responded to Aurora Cannabis’ (ACB) latest public statements regarding Curaleaf’s offer for Aurora, stating in part: “Aurora’s hollow protests and completely misleading stati...
Curaleaf Responds to Aurora Cannabis' Latest Attempt to Deflect From Shareholder Value Creation
Aurora's selective statistics and misleading characterization of engagement do not obscure years of underperformance and lost shareholder value Curaleaf reiterates its willingness to meet anytime to d...
Aurora Cannabis says Curaleaf takeover bid ‘should be viewed skeptically’
Aurora Cannabis (ACB) cautioned shareholders that Curaleaf Holdings (CURLF) announcement of an unsolicited take-over bid appears to contain inaccurate statements about Aurora’s business and should be ...
AURORA CANNABIS CORRECTS INACCURATE STATEMENTS MADE IN SUPPORT OF CURALEAF HOLDINGS' HOSTILE BID
Curaleaf's self-serving portrayal of our business is an attempt to acquire Aurora's world class EU-GMP manufacturing facilities and global medical cannabis footprint at the lowest price possible Auror...
The Cannabis M&A Wave Is Here. Curaleaf Proved It.
Green Thumb Industries is one of the few U.S. cannabis companies that has been consistently profitable. The company grew revenue and earnings in the second quarter.
Curaleaf's Hostile Takeover Bid for Aurora Is Just the Tip of the Iceberg for Cannabis Consolidation. These 2 Stocks Could Be the Biggest Winners.
Curaleaf has made an unsolicited bid for Aurora Cannabis. Aurora recently completed its acquisition of Safari Flower.
Is Curaleaf Stock a Buy With Its Attempted Hostile Takeover of Aurora Cannabis Under Way?
Curaleaf reiterated the offer it made public last week. Aurora stock continues to trade at a discount to the base offer price.
Aurora Cannabis acquires Internode Pharma, HAP Pharma for GBP 2.1M
Aurora Cannabis (ACB) has acquired Internode Pharma, a licensed importer and wholesaler, and HAP Pharma, a licensed pharmacy. The Companies operate a licensed import and distribution facility and a vi...
Aurora Cannabis Furthers Global Medical Cannabis Growth with Accretive Acquisition of Internode Pharma Limited and HAP Pharma Limited, Expanding Distribution Access to the UK Medical Cannabis Market
EDMONTON, AB, Aug. 19, 2026 /PRNewswire/ -- Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, is pleased to announc...
Aurora Cannabis urges no shareholder action regarding Curaleaf takeover bid
Aurora Cannabis (ACB) confirmed that Curaleaf Holdings (CURLF), has commenced an unsolicited take-over bid for all of the issued and outstanding common shares of the company at a stated implied…
AURORA CANNABIS INC. URGES SHAREHOLDERS TO TAKE NO ACTION AT THIS TIME IN RESPECT TO THE UNSOLICITED TAKE-OVER BID BY CURALEAF HOLDINGS, INC.
Curaleaf's decision to launch a hostile takeover bid is designed to pressure Aurora's shareholders into a short-term decision for the benefit of Curaleaf shareholders. Curaleaf's actions and comments ...
Curaleaf CEO talks unsolicited offer to buy Aurora Cannabis
Curaleaf Chairman and CEO Boris Jordan joins 'Fast Money' to talk the cannabis company's bid for Aurora Cannabis.
Curaleaf CEO talks unsolicited offer to buy Aurora Cannabis
Curaleaf Chairman and CEO Boris Jordan joins 'Fast Money' to talk the cannabis company's bid for Aurora Cannabis.
M&A News: Aurora Cannabis Stock (ACB) Rises on $260 Million Takeover Bid
Canada’s cannabis industry has struggled mightily.
Curaleaf launches US$260 million takeover bid for Canadian producer Aurora Cannabis
U.S.-based cannabis firm Curaleaf Holdings said it has launched a takeover bid for Aurora Cannabis valuing the Canadian peer at about US$260 million.
Curaleaf launches $4.00 per share take over bid for Aurora Cannabis
Curaleaf Holdings (CURLF) announced that it has formally commenced its previously announced proposal to purchase all of the issued and outstanding common shares of Aurora Cannabis (ACB). Under the ter...
Curaleaf launches $4.00 per share take over bid for Aurora Cannabis
08:02 EDT Curaleaf (CURLF) launches $4.00 per share take over bid for Aurora Cannabis (ACB)
Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target?
Curaleaf's bid signals cannabis consolidation is accelerating. Canopy Growth could emerge as another takeover candidate.
Marijuana reform is emerging as a midterm elections issue on both sides of the aisle
With November's pivotal midterm elections fast approaching, cannabis reform is emerging as an issue. Two states, Massachusetts and Idaho, will vote on ballot initiatives regarding legalization, and in...
Will Canopy Growth Get Acquired?
Curaleaf is attempting to acquire Canopy Growth's rival, Aurora Cannabis, and there could be more consolidation to come in the industry.
Is Acquiring Aurora Cannabis a Good Move for Curaleaf?
Curaleaf has announced a hostile bid for Aurora Cannabis. Aurora has a strong international presence, but it's had challenges with staying out of the red.
Aurora Cannabis (ACB) Q1 2027 Earnings Call Transcript
German market expansion drove $43M in international medical cannabis revenue amid Canadian pricing pressure.
Curaleaf Just Announced a Hostile Takeover Bid for Aurora Cannabis. Here's What This Means for Investors.
Aurora criticized key aspects of the bid, but will consider it. The major appeal of Aurora is its strong medical marijuana business.